ASM in CF
Research type
Research Study
Full title
ASM in CF: ADAM Sensor Monitoring in Cystic Fibrosis
IRAS ID
297622
Contact name
Andres Floto
Contact email
Sponsor organisation
Royal Papworth Hospital NHS Foundation Trust
Duration of Study in the UK
0 years, 6 months, 2 days
Research summary
This is a 6-month single-centre observational, prospective study, designed as a pilot study. We aim to recruit 10 adult patients with Cystic Fibrosis (CF) who are already participating in the Project Breathe home monitoring project at Royal Papworth Hospital. Participants will be enrolled for 6 weeks.
This study is designed to run as a non-disruptive study with no impact on routine clinical care and the sensor data will have no influence on treatment decisions.
The aim of this study is to explore the potential use of the ADAM sensor to assist or improve the detection of health conditions in people with CF. The emphasis is on identifying onset and progression of pulmonary exacerbations.
REC name
West Midlands - Solihull Research Ethics Committee
REC reference
21/WM/0165
Date of REC Opinion
11 Aug 2021
REC opinion
Further Information Favourable Opinion